Sangamo Therapeutics (GBY.F) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.13
-0.07
-0.02
0.04

Details

Expected EPS
-0.00862057344
Actual EPS
-0.0685056
Surprise EPS
-0.06
Surprise Percent
+694.68%

Description

Sangamo Therapeutics (GBY.F) has reported earnings of -0.0685056 per share for Q3 2025.

0 Comments

Share your thoughts